BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4696151)

  • 1. Studies on different stages in host-tumor relationship. 1. Differences in the behavior in vitro of ascites cells and lymphocytes derived from mice in early and later stages of tumor growth.
    Pikovski MA
    Isr J Med Sci; 1973 Feb; 9(2):136-44. PubMed ID: 4696151
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the tumor-host relationship. II. Serum resistant factor(s) produced by tumor transplantation.
    Tanino T
    Jpn J Exp Med; 1968 Oct; 38(5):383-92. PubMed ID: 5305973
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of normal T lymphocytes in tumor-bearing rats.
    Klobusická M; Koníková E
    Neoplasma; 1982; 29(6):727-34. PubMed ID: 6984490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tumor growth on migratory properties of T lymphocytes in rats.
    Klobusická M; Koníková E; Novotná L
    Neoplasma; 1980; 27(6):675-82. PubMed ID: 6973097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
    Wiltrout RH; Frost P
    J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of progressive neoplastic growth on the decarboxylation of DL-[1-14C]ornithine by lymphocytes from C3H/He tumor hosts.
    Vaage J; Agarwal S; Reinertsen JL
    Cancer Res; 1978 Aug; 38(8):2253-8. PubMed ID: 667820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of immune response to sheep red blood cells in mice treated with preparations of a tumor cell component and in tumor-bearing mice.
    Pikovski MA; Ziffroni-Gallon Y; Witz IP
    Eur J Immunol; 1976 Jul; 5(7):447-50. PubMed ID: 1086244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
    Patel M; Havas HF
    Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of spleen cells on cytotoxicity by immune lymph node cells: cell-mediated immune suppression (? enhancement) in vitro.
    Klein WJ
    J Immunol; 1972 Jul; 109(1):51-8. PubMed ID: 5035245
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on target cell destruction.
    Kikuchi K
    Jpn J Med Sci Biol; 1971 Jun; 24(3):193-4. PubMed ID: 5315162
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of "monocytic sarcoma of the peritoneal type" with minimal involvement of the bone marrow, liver, spleen, and lymph node (author's transl)].
    Deura K; Ishii Z; Shimoyama M; Minato K; Matsuda M
    Rinsho Ketsueki; 1978 Oct; 19(10):1372-8. PubMed ID: 739599
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electric charge of the surface of lymphocytes and their ability to divide mitotically during induced carcinogenesis].
    Shkarina TN; Zatsepina GN; Kasatkina VV; Kozinets GI; Tarasova IM
    Biofizika; 1984; 29(1):96-9. PubMed ID: 6713011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic obstruction in carcinomatous ascites.
    Feldman GB
    Cancer Res; 1975 Feb; 35(2):325-32. PubMed ID: 1109800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological evidences for proliferation and migration of lymphocytes induced by administration of potent antitumor phosphomucolipid in tumor-bearing mice.
    Mita A
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):860-7. PubMed ID: 4569609
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for several cell populations active in antibody dependent cellular cytotoxicity.
    Zighelboim J; Bonavida B; Fahey JL
    J Immunol; 1973 Dec; 111(6):1737-42. PubMed ID: 4750865
    [No Abstract]   [Full Text] [Related]  

  • 18. [Morphological studies in syngenic tumor-carriers after splenectomy].
    Zarudin VV; Shcherbakov VIa
    Arkh Patol; 1974; 36(4):56-61. PubMed ID: 4457085
    [No Abstract]   [Full Text] [Related]  

  • 19. In-vitro and in-vivo adherence of allergised lymph-node cells to BP8 ascites tumour cells, in the presence of polyamines and quarternary ammonium compounds.
    Crocker J; Cater DB
    J Pathol; 1973 Apr; 109(4):323-34. PubMed ID: 4720913
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. Cytotoxic activity of the antibodies].
    Valguarnera G
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):1013-6. PubMed ID: 4463978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.